Market Insights
The point-of-care diagnostics/testing (POCT) report studies various products and end-user markets. POCT is considered one of the most affordable technologies of the global diagnostics market, and development in POCT technologies over a period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies. According to market experts, the factors assisting the growth of the POC diagnostics market are several government initiatives that have aided in developing innovative outpatient care models to minimize hospital stays and rapidly increasing demand for home healthcare globally.
For the purpose of this study, the global point of care diagnostics market based on product type is segmented into glucose monitoring, urinalysis testing, cardiac markers, infectious diseases testing, cholesterol testing, coagulation monitoring, pregnancy and fertility testing, hematology testing, fecal occult testing kits, blood gas testing, cancer markers, drugs of abuse testing, and others. Market size estimates and forecasts for these segments for 2020 to 2029 are provided in terms of USD Mn and the respective compounded annual growth rates (CAGRs) for 2022 to 2029, considering 2021 as the base year.
Based on end-users point of care diagnostic market is segmented as clinics, homes, laboratories, assisted living healthcare facilities, and hospitals. The diagnostic tests performed on a large scale in these healthcare institutes and the increasing demand for further expansion of point-of-care diagnostic facilities are the key factors fueling the growth of point of care diagnostics market in hospitals and clinics. Therefore, market size estimates and forecasts for these segments for 2020 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2022 to 2029, considering 2021 as the base year.
The POC diagnostics and testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K., Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2020 to 2029 and their CAGRs for the period 2022 to 2029 are provided in this report.
The key manufacturers from the point-of-care diagnostics market are carrying out constant efforts and huge investments on the research and development of innovative products which are enabled with advanced technologies. The major key players profiled in the POC diagnostics and testing market are based on various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Roche Diagnostics Ltd., Alere Inc., Siemens AG, and Beckman Coulter, Inc., Johnson & Johnson, Bayer AG, and Abbott Laboratories, Abaxis, Inc., Becton, Dickinson And Company, and Nipro Diagnostics, Inc.
By Products
Based on the type of products, the global point-of-care diagnostics/testing (POCT) market is segmented as follows:
- Glucose Monitoring
- Cardiac Markers
- Infectious Diseases Testing
- Cholesterol Testing
- Coagulation Monitoring
- Pregnancy And Fertility Testing
- Hematology Testing
- Blood Gas Testing
- Others (Fecal Occult Testing, Cancer Markers, Urinalysis Testing, Drugs Of Abuse Testing, etc.)
In year 2021, the glucose monitoring segment accounted for the largest market share in the POCT market. The incidences and prevalence of diabetes and the requirement of regular measurement of sugar levels in the blood are the key factors driving the point-of-care glucose monitoring market. According to International Diabetes Federation (IDF), the number of people living with the disease is expected to soar to 552 million by 2030 — equating to three new cases every 10 seconds — up from 366 million in 2011. However, the rapid diagnostics market and OTC is expected to show lucrative growth over the forecast period owing to the rising demand for early disease diagnosis and self-diagnosis to instigate immediate and on-time treatment of chronic diseases.
By End Users
Based on the end-users, the point-of-care diagnostics/testing (POCT) market is segmented into:
- Clinics
- Home
- Laboratories
- Assisted living healthcare facilities
- Hospitals
In the base year 2021, the clinics and hospitals collectively attribute the largest share in the market in terms of revenue. This is because diagnostic tests are carried out on a large scale in these healthcare institutes, and the rising demand for accessible and patient-compliant diagnostics technologies are the key factors fueling the growth of the POC diagnostics market in hospitals and clinics. Moreover, with the aging patient base worldwide and the rising demand for assisted and home healthcare technologies, the point-of-care diagnostic market is expected to show lucrative growth over the forecast period 2022 – 2029.
By Geography
For the purpose of this study, the global point-of-care diagnostics or testing (POCT) market is categorized into:
- North America
- Europe
- Germany
- France
- UK.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
In the base year 2021, North America accounted for the largest share in the global POCT market, followed by Asia-Pacific, Europe, and the RoW (The rest of the World). The Asia-Pacific region (comprising Japan, China, and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2022 – 2029. The key factors assisting the growth of the point-of-care diagnostics market in the Asia-Pacific region are the huge patient population base, the large number of R&D activities carried out in the diagnostics field, rising focus of both international and domestic players on the Asia-Pacific POCT market, and increasing funding/investment towards the development of Point-Of-Care Diagnostics / Testing products.
